Login

Surface Oncology, Inc. SEC Filings

Filed On Filing
18 Sep 2023 15-12G
12 Sep 2023 EFFECT
12 Sep 2023 EFFECT
08 Sep 2023 S-8 POS
08 Sep 2023 S-8 POS
08 Sep 2023 S-8 POS
08 Sep 2023 S-8 POS
08 Sep 2023 S-8 POS
08 Sep 2023 S-8 POS
08 Sep 2023 POS AM
08 Sep 2023 POS AM
08 Sep 2023 Form 4: Sigal Charles Elliott, Director

Returned 45,453 shares to the issuer · Disposed of 113,636 Stock Option (Right to Buy) (Disposition to Issuer)

08 Sep 2023 Form 4: Adams Chandra, Deputy GC

Returned 23,884 shares to the issuer · Disposed of 100,000 Stock Option (Right to Buy) (Disposition to Issuer)

08 Sep 2023 Form 4: Rath Henry C., Chief Business Officer

Returned 44,971 shares to the issuer · Disposed of 150,000 Stock Option (Right to Buy) (Disposition to Issuer)

08 Sep 2023 Form 4: Palombella Vito J., Chief Scientific Officer

Returned 87,212 shares to the issuer · Disposed of 150,000 Stock Option (Right to Buy) (Disposition to Issuer)

08 Sep 2023 Form 4: Goater Jeff, Director

Returned 129,222 shares to the issuer

08 Sep 2023 Form 4: Fees Jessica, Chief Financial Officer

Returned 101,915 shares to the issuer · Disposed of 150,000 Stock Option (Right to Buy) (Disposition to Issuer)

08 Sep 2023 Form 4: Ross Robert W., Director

Returned 83,193 shares to the issuer · Disposed of 400,000 Stock Option (Right to Buy) (Disposition to Issuer)

08 Sep 2023 Form 4: Grayzel David S., Director

Returned 2,945,453 shares to the issuer

08 Sep 2023 Form 4: Oneill Alison, Chief Medical Officer

Returned 56,686 shares to the issuer · Disposed of 150,000 Stock Option (Right to Buy) (Disposition to Issuer)

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support